MB
Mustang Bio Inc
🇺🇸XNAS.MBIOUnited StatesHealthcare
$0.50USDdown -0.01 (-1.96%)ClosedEnd of day8:57 PM
Price$0.50-0.01 (-1.96%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US62818Q3020
- CUSIP
- 62818Q104
Company
- Employees
- 4
- Headquarters
- Waltham, United States
- Website
- https://www.mustangbio.com
- CEO
- Dr. Manuel Litchman M.D.
Market
- Shares outstanding
- 6.7M
- Market cap
- $3.37M
Key dates
- Next earnings
- Nov 6, 2026
Highlights
- Market cap
- $3.37M
- EPS LTM
- -$0.45calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -1.11calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- 5.79%
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- -$3.03M+7.45%up year on year
- Gross margin
- Not reported
- Free cash flow
- -$4.51M+30.41%up year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.